Pharming Group to participate in November investor conference
05 nov. 2024 02h00 HE
|
Pharming Group N.V.
Leiden, the Netherlands, November 5, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor...
OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference
30 oct. 2024 07h00 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Oct. 30, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic...
Cyclacel Pharmaceuticals Announces Participation at the H.C. Wainwright 26th Annual Global Investment Conference
04 sept. 2024 09h15 HE
|
Cyclacel
Cyclacel to participate at the H.C. Wainwright 26th Annual Global Investment Conference
Pharming Group to participate in September investor conferences
04 sept. 2024 01h00 HE
|
Pharming Group N.V.
Leiden, the Netherlands, September 4, 2024: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming’s management will participate in the following investor...
Arbutus to Participate in Two Upcoming Investor Conferences
03 sept. 2024 07h30 HE
|
Arbutus Biopharma Corporation
WARMINSTER, Pa., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company leveraging its extensive...
FRO – Q2 2024 Presentation
30 août 2024 08h17 HE
|
Frontline plc.
Please find enclosed the presentation of Frontline plc´s second quarter 2024 results to be held on the webcast / conference call 30 August, 2024 at 15:00 CET. This information is subject to the...
Recent and Upcoming McEwen Mining and McEwen Copper Presentations
22 août 2024 19h05 HE
|
McEwen Mining
TORONTO, Aug. 22, 2024 (GLOBE NEWSWIRE) -- McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) and McEwen Copper Inc. are pleased to announce their participation in Fastmarkets’ “Argentina: An emerging...
Crossject participera à la 26ème Annual Global Investment Conference de H.C. Wainwright, 9 au 11 septembre 2024
22 août 2024 01h30 HE
|
CROSSJECT
Communiqué de Presse Dijon, France, le 22 août 2024 07:30 CET — Crossject (ISIN : FR0011716265 ; Euronext : ALCJ), une société pharmaceutique spécialisée qui développe des médicaments dédiés aux...
Crossject to Present at the H.C. Wainwright 26th Annual Global Investment Conference, September 9th-11th, 2024
22 août 2024 01h30 HE
|
CROSSJECT
Press Release Dijon, France August 22, 2024 07:30 CET -- Crossject (ISIN: FR0011716265; Euronext: ALCJ), a specialty pharma company developing medicines for emergency situations harnessing its...
OKYO Pharma Participates in H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
15 août 2024 12h13 HE
|
OKYO Pharma LTD
LONDON and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative ocular therapies for the treatment of...